These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 29800690)

  • 1. Cochrane acute respiratory infections group's stakeholder engagement project identified systematic review priority areas.
    Scott AM; Clark J; Dooley L; Jones A; Jones M; Del Mar C
    J Clin Epidemiol; 2018 Oct; 102():63-68. PubMed ID: 29800690
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of the Cochrane Consumers and Communication Group's systematic review priority-setting project.
    Synnot A; Tong A; Ryan R; Hill S
    Health Res Policy Syst; 2020 Sep; 18(1):98. PubMed ID: 32878617
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Selecting, refining and identifying priority Cochrane Reviews in health communication and participation in partnership with consumers and other stakeholders.
    Synnot AJ; Tong A; Bragge P; Lowe D; Nunn JS; O'Sullivan M; Horvat L; Kay D; Ghersi D; McDonald S; Poole N; Bourke N; Lannin NA; Vadasz D; Oliver S; Carey K; Hill SJ
    Health Res Policy Syst; 2019 Apr; 17(1):45. PubMed ID: 31036016
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identifying and prioritising systematic review topics with public health stakeholders: A protocol for a modified Delphi study in Switzerland to inform future research agendas.
    Hoekstra D; Mütsch M; Kien C; Gerhardus A; Lhachimi SK
    BMJ Open; 2017 Aug; 7(8):e015500. PubMed ID: 28780546
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Setting research priorities in tobacco control: a stakeholder engagement project.
    Lindson N; Richards-Doran D; Heath L; Hartmann-Boyce J;
    Addiction; 2017 Dec; 112(12):2257-2271. PubMed ID: 28879662
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Determining the gaps between Cochrane reviews and trials of effectiveness of interventions for acute respiratory infections: an audit.
    Alloo J; Vallath S; Del Mar C; Carter M; Thorning S; Clark J
    Syst Rev; 2017 Apr; 6(1):82. PubMed ID: 28407780
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The TRIP database showed most acute respiratory infections questions were already addressed by Cochrane reviews.
    Clark J; Carter M; Scott AM; Brassey J; Del Mar C
    J Clin Epidemiol; 2019 Mar; 107():60-65. PubMed ID: 30439545
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identifying unanswered questions and setting the agenda for future systematic research in Multiple Sclerosis. A worldwide, multi-stakeholder Priority Setting project.
    Celani MG; Nonino F; Mahan K; Orso M; Ridley B; Baldin E; Bignamini AA; D'Amico R; Cantisani TA; Colombo C; Khan F; Köpke S; Laurson-Doube J; Schvarz C; Young CA; Peryer G; Rosati P; Filippini G
    Mult Scler Relat Disord; 2022 Apr; 60():103688. PubMed ID: 35245817
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Cochrane Library review titles that are important to users of health care, a Cochrane Consumer Network project.
    Wale JL; Belizán M; Nadel J; Jeffrey C; Vij SL
    Health Expect; 2013 Dec; 16(4):e146-63. PubMed ID: 21895902
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Procalcitonin to initiate or discontinue antibiotics in acute respiratory tract infections.
    Schuetz P; Wirz Y; Sager R; Christ-Crain M; Stolz D; Tamm M; Bouadma L; Luyt CE; Wolff M; Chastre J; Tubach F; Kristoffersen KB; Burkhardt O; Welte T; Schroeder S; Nobre V; Wei L; Bucher HC; Bhatnagar N; Annane D; Reinhart K; Branche A; Damas P; Nijsten M; de Lange DW; Deliberato RO; Lima SS; Maravić-Stojković V; Verduri A; Cao B; Shehabi Y; Beishuizen A; Jensen JS; Corti C; Van Oers JA; Falsey AR; de Jong E; Oliveira CF; Beghe B; Briel M; Mueller B
    Cochrane Database Syst Rev; 2017 Oct; 10(10):CD007498. PubMed ID: 29025194
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Priority setting to support a public health research agenda: a modified Delphi study with public health stakeholders in Germany.
    Hoekstra D; Gerhardus A; Lhachimi SK
    Health Res Policy Syst; 2023 Aug; 21(1):86. PubMed ID: 37641128
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A survey and stakeholder group prioritised key systematic review questions in airways disease.
    Dennett EJ; Stovold EM; Fortescue R
    Dialogues Health; 2022 Dec; 1():100028. PubMed ID: 38515910
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The trials methodological research agenda: results from a priority setting exercise.
    Tudur Smith C; Hickey H; Clarke M; Blazeby J; Williamson P
    Trials; 2014 Jan; 15():32. PubMed ID: 24456928
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Procalcitonin to initiate or discontinue antibiotics in acute respiratory tract infections.
    Schuetz P; Müller B; Christ-Crain M; Stolz D; Tamm M; Bouadma L; Luyt CE; Wolff M; Chastre J; Tubach F; Kristoffersen KB; Burkhardt O; Welte T; Schroeder S; Nobre V; Wei L; Bhatnagar N; Bucher HC; Briel M
    Evid Based Child Health; 2013 Jul; 8(4):1297-371. PubMed ID: 23877944
    [TBL] [Abstract][Full Text] [Related]  

  • 16. What are the most important unanswered research questions in trial retention? A James Lind Alliance Priority Setting Partnership: the PRioRiTy II (Prioritising Retention in Randomised Trials) study.
    Brunsdon D; Biesty L; Brocklehurst P; Brueton V; Devane D; Elliott J; Galvin S; Gamble C; Gardner H; Healy P; Hood K; Jordan J; Lanz D; Maeso B; Roberts A; Skene I; Soulsby I; Stewart D; Torgerson D; Treweek S; Whiting C; Wren S; Worrall A; Gillies K
    Trials; 2019 Oct; 20(1):593. PubMed ID: 31615577
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The future of Cochrane Neonatal.
    Soll RF; Ovelman C; McGuire W
    Early Hum Dev; 2020 Nov; 150():105191. PubMed ID: 33036834
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Procalcitonin to initiate or discontinue antibiotics in acute respiratory tract infections.
    Schuetz P; Müller B; Christ-Crain M; Stolz D; Tamm M; Bouadma L; Luyt CE; Wolff M; Chastre J; Tubach F; Kristoffersen KB; Burkhardt O; Welte T; Schroeder S; Nobre V; Wei L; Bhatnagar N; Bucher HC; Briel M
    Cochrane Database Syst Rev; 2012 Sep; 2012(9):CD007498. PubMed ID: 22972110
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A common framework of steps and criteria for prioritizing topics for evidence syntheses: a systematic review.
    Fadlallah R; El-Harakeh A; Bou-Karroum L; Lotfi T; El-Jardali F; Hishi L; Akl EA
    J Clin Epidemiol; 2020 Apr; 120():67-85. PubMed ID: 31846688
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prioritising models of healthcare service delivery for a more sustainable health system: a Delphi study of Australian health policy, clinical practice and management, academic and consumer stakeholders.
    Putrik P; Jessup R; Buchbinder R; Glasziou P; Karnon J; O Connor DA
    Aust Health Rev; 2021 Aug; 45(4):425-432. PubMed ID: 33731250
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.